Overview of regular dialysis treatment in Japan (as of 31 December 2009)

Shigeru Nakai1, Kunitoshi Iseki, Noritomo Itami

  • 1Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.

Insights

Dialysis patient numbers increased in 2009, with diabetic nephropathy as a primary cause. Most facilities met microbiological standards for dialysis fluids, but patient satisfaction with secondary hyperparathyroidism management varied.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • The number of patients requiring dialysis is increasing globally.
  • Understanding the demographics, primary diseases, and quality of care in dialysis facilities is crucial for public health.
  • The Japanese Society for Dialysis Therapy (JSDT) sets standards for dialysis fluid quality and treatment targets.

Purpose of the Study:

  • To present a nationwide statistical overview of dialysis patients and facilities in Japan at the end of 2009.
  • To analyze the characteristics of new and existing dialysis patients, including primary diseases and age.
  • To assess the adherence of dialysis facilities to microbiological standards and patient satisfaction with secondary hyperparathyroidism management.

Main Methods:

  • A nationwide statistical survey of dialysis facilities in Japan was conducted.
  • Data collected included the number of dialysis patients, patient demographics, primary diseases, and facility adherence to JSDT standards.
  • Patient satisfaction with secondary hyperparathyroidism management and complication rates were also assessed.

Main Results:

  • In 2009, 290,661 patients underwent dialysis, a 2.6% increase from 2008. The crude death rate was 9.6%.
  • Diabetic nephropathy (44.5%) and chronic glomerulonephritis (21.9%) were leading causes for new dialysis patients, with a mean age of 67.3 years.
  • 84.2% of facilities met microbiological standards for dialysis fluids; 24.8% of patients were satisfied with secondary hyperparathyroidism management targets.

Conclusions:

  • The dialysis patient population in Japan continues to grow, with significant contributions from diabetic nephropathy.
  • While most facilities adhere to microbiological standards for dialysis fluids, there is room for improvement in patient satisfaction with secondary hyperparathyroidism management.
  • Ongoing monitoring and quality improvement initiatives are essential for the dialysis patient population.

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...